1. Home
  2. CNET vs ARTL Comparison

CNET vs ARTL Comparison

Compare CNET & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZW Data Action Technologies Inc.

CNET

ZW Data Action Technologies Inc.

HOLD

Current Price

$1.45

Market Cap

4.0M

ML Signal

HOLD

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.84

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNET
ARTL
Founded
2003
2011
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
3.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CNET
ARTL
Price
$1.45
$1.84
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$30.00
AVG Volume (30 Days)
5.3K
1.3M
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,166,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$1.52
52 Week High
$2.78
$28.60

Technical Indicators

Market Signals
Indicator
CNET
ARTL
Relative Strength Index (RSI) 37.35 33.96
Support Level $1.23 $1.62
Resistance Level $1.59 $1.98
Average True Range (ATR) 0.10 0.19
MACD -0.01 0.11
Stochastic Oscillator 31.84 69.53

Price Performance

Historical Comparison
CNET
ARTL

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: